FDA Inspection 1156634 — Prescription Dispensing Laboratories Inc.
The FDA completed an inspection of Prescription Dispensing Laboratories Inc. on Oct 5, 2021 in Cedar Park, TX. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2021
- Fiscal Year
- 2022
- Product Type
- Drugs
- Project Area
- Drug Quality Assurance
- Location
- Cedar Park, TX (United States)